Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-11-01FDA Approved: GAZYVA — Original Application (Genentech, Inc.)
FDA approved GAZYVA (obinutuzumab) from Genentech in its original application for the treatment of chronic lymphocytic leukemia, in combinat…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating Triapine (3-AP) in combination with gemcitabine in patients with advanced solid tumors or lymphoma has completed. I…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine in combination with valproic acid for adults with refractory or relapsed acute myeloid leukemia or previ…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older [Phase 2]
Phase 2 clinical trial update evaluating lenalidomide as initial treatment in older patients with chronic lymphocytic leukemia; results post…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with interleukin-12 in several B-cell non-Hodgkin lymphomas. The study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial of bendamustine plus alemtuzumab in refractory chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated. The…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating Apolizumab in patients with relapsed or refractory chronic lymph…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 trial evaluating alvocidib (flavopiridol) for chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma [Phase 2]
A terminated Phase 2 trial evaluated FR901228 alone or with Rituximab and Fludarabine in relapsed or refractory low-grade B-cell non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial testing Rituximab plus Beta-Glucan in chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial of thalidomide with or without fludarabine in patients with small lymphocytic lymphoma and chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma [Phase 1]
Phase 1 study evaluating a combination of alvocidib, fludarabine phosphate, and rituximab in various B-cell lymphoproliferative disorders, w…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of a monoclonal antibody therapy in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating a monoclonal antibody in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lympho…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis [Phase 2]
Phase 2 study update analyzing DNA microarray gene expression in chronic lymphocytic leukemia and small lymphocytic lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating preemptive immunointervention after allogeneic hematopoietic stem ce…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [NA]
A clinical trial evaluated arsenic trioxide in patients with relapsed or refractory lymphoma and leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This update reports the completion of a Phase 2 trial of perifosine in relapsed or refractory chronic lymphocytic leukemia and small lymphoc…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma [Phase 2]
A Phase 2 trial investigating 506U78 in patients with recurrent or refractory non-Hodgkin's lymphoma and T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating thalidomide in relapsed or refractory non-Hodgkin lymphoma has completed enrollment. The study included patients wi…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 study of EL625 in patients with persistent chronic lymphocytic leukemia or small lymphocytic lymphoma was terminated, with results…
-
FDA approval · 2012-06-26FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.